Literature DB >> 1972466

Distinguishing between HTLV-I and HTLV-II by western blot.

S Z Wiktor, S S Alexander, G M Shaw, S H Weiss, E L Murphy, R J Wilks, V J Shortly, B Hanchard, W A Blattner.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 1972466     DOI： 10.1016/0140-6736(90)93078-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  A new and frequent human T-cell leukemia virus indeterminate Western blot pattern: epidemiological determinants and PCR results in central African inhabitants.

Authors:  Claudia Filippone; Sylviane Bassot; Edouard Betsem; Patricia Tortevoye; Micheline Guillotte; Odile Mercereau-Puijalon; Sabine Plancoulaine; Sara Calattini; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2012-03-07       Impact factor: 5.948

2.  Prevalence of human T-lymphotropic virus in civilian applicants for the United States Armed Forces.

Authors:  C R Roberts; D R Fipps; J F Brundage; S E Wright; M Goldenbaum; S S Alexander; D S Burke
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

Review 3.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

4.  Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by the immunofluorescence method.

Authors:  D Gallo; L M Penning; C V Hanson
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji.

Authors:  E Chungue; J P Boutin; L Le Marchand; G Philippon; A Le Guellec; S Chanteau; J L Cartel; C Gras; P M Martin; J F Roux
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

6.  Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain.

Authors:  E J Calderón; C Rey; F J Medrano; J Sánchez-Román; V Soriano; Y Torres; M Ruiz; E Lissen; M Leal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

7.  Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.

Authors:  D Agranoff; K Varney; H Khayam-Bashi; E L Murphy
Journal:  West J Med       Date:  1996-06

8.  Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

Authors:  R B Lal; W Heneine; D L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

Authors:  B D Roberts; S K Foung; J J Lipka; J E Kaplan; K G Hadlock; G R Reyes; L Chan; W Heneine; R F Khabbaz
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

10.  Human T-lymphotropic virus type I seroprevalence among Japanese Americans.

Authors:  E L Murphy; K F Varney; N T Miyasaki; R J Moore; J I Umekubo; A N Watanabe; H Khayam-Bashi
Journal:  West J Med       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.